Relief Therapeutics Holding Surges on Corporate Update
Relief ticker, $RLFTF, has surged in the last couple of days on positive news. This is not a sponsored post, I’m just an…
The FDA Declines EUA of Zyesami (aviptadil) for Patients with Critical COVID-19 with Respiratory Failure
It was never an impressive sample size, wouldn’t a company the size of NRx Pharmaceuticals, Inc. $NRXP know better? Something doesn’t add up…
Relief Therapeutics Reports Corporate Update
The star swiss micro cap pharma company is becoming a decent bet in the middle of a bear market for penny stocks. Micro…
Relief Therapeutics EUA for Zyesami Expanding to More Countries
More countries including the Nation of Georgia have issued an Emergency Use Authorization (EUA) for intravenous aviptadil for the treatment of critical COVID-19….
The Top Covid-19 Stock of the Delta Wave
Relief Therapeutics has had a credibility breakthrough. With the stock of its western partner surging, $NRXP 98.5% in the last five days, we…
Zyesami (Aviptadil) Prevents a Sharp Rise in Cytokines
At the Last Futurist we have been bullish in our opinion that the best penny stock that’s covid-19 related is ticker $RLFTF. The…
Relief Therapeutics is a Covid-19 Play that Delta Will Help
We recently found out that Delta is 40-60% more contagious than Alpha. $RLFTF is up 34% in the last month up to $0.27….
India’s Best Chance with Covaxin
India’s best chance against its recent outbreak is to get other countries to produce Covaxin. Covaxin is India’s most effective vaccine vs. its…
Is Ocugen Stock a Logical Speculative Buy?
There are a lot of opinions on Ocugen’s stock and its meteoritical rise already has the appearance of a pump and dump, but…
Relief Therapeutics Caught in ‘Culture Mismatch’ in Partnership between Swiss and American Business Leaders
At the Last Futurist, we’ve never seen PR that echoes partner disagreements with corporate partners across the pond. But if anything, this looks…